CI Investments Inc’s Kura Oncology KURA Stock Holding History

CI Investments Inc’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-84,902	Closed	-$1.36M	–	1336
2022 Q1	$1.36M	Buy	+84,902	New	+$1.23M	0.01%	405

Other funds holding KURA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CI Investments Inc's KURA Position: Q2 2022 in Review

CI Investments Inc sold out of Kura Oncology (KURA) in Q2 2022, closing a stake of 84,902 shares — an estimated $1.36M sold.

CI Investments Inc first reported a position in KURA in Q1 2022 and held it in 1 quarter. The position peaked at $1.36M in Q1 2022. 148 funds tracked by Wall St. Rank hold KURA as of Q2 2022.

CI Investments Inc reported no remaining Kura Oncology position as of Q2 2022 after selling out during the quarter.
CI Investments Inc sold 84,902 Kura Oncology shares in Q2 2022, an estimated $1.36M.
CI Investments Inc first reported a position in Kura Oncology in Q1 2022 and held it in 1 quarter.
CI Investments Inc's Kura Oncology position peaked at $1.36M in Q1 2022.
148 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2022.

Based on CI Investments Inc's 13F filing for Q2 2022, filed 12 Aug 2022.